185 related articles for article (PubMed ID: 25867530)
1. Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure.
Adam M; Meyer S; Knors H; Klinke A; Radunski UK; Rudolph TK; Rudolph V; Spin JM; Tsao PS; Costard-Jäckle A; Baldus S
Sci Rep; 2015 Apr; 5():9704. PubMed ID: 25867530
[TBL] [Abstract][Full Text] [Related]
2. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
Despas F; Trouillet C; Franchitto N; Labrunee M; Galinier M; Senard JM; Pathak A
Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264
[TBL] [Abstract][Full Text] [Related]
3. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
5. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
6. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
[TBL] [Abstract][Full Text] [Related]
7. Value of IGF-I levels in the evaluation of response to treatment with levosimendan in patients with severe heart failure.
Işık S; Cetin M; Ciçekçioğlu H; Uçar O; Çetin ZG; Ozuğuz U; Bakır F; Berker D; Güler S
Anadolu Kardiyol Derg; 2011 Sep; 11(6):523-9. PubMed ID: 21821501
[TBL] [Abstract][Full Text] [Related]
8. [Levosimendan for treatment of heart failure].
Yasumura Y
Nihon Rinsho; 2007 May; 65 Suppl 5():169-72. PubMed ID: 17571380
[No Abstract] [Full Text] [Related]
9. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY
Cardiovasc Ther; 2013 Apr; 31(2):108-14. PubMed ID: 23490237
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of levosimendan in decompensated heart failure: impact on weight loss and anemia.
Parissis JT; Farmakis D; Kremastinos DT
Am J Cardiol; 2005 Apr; 95(7):923-4. PubMed ID: 15781038
[No Abstract] [Full Text] [Related]
12. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure.
Parissis JT; Adamopoulos S; Antoniades C; Kostakis G; Rigas A; Kyrzopoulos S; Iliodromitis E; Kremastinos D
Am J Cardiol; 2004 May; 93(10):1309-12. PubMed ID: 15135713
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study.
Hasslacher J; Bijuklic K; Bertocchi C; Kountchev J; Bellmann R; Dunzendorfer S; Joannidis M
Crit Care; 2011 Jul; 15(4):R166. PubMed ID: 21749676
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan.
Kamath SR; Jaykumar I; Matha S
Indian Pediatr; 2009 Jul; 46(7):593-6. PubMed ID: 19638658
[No Abstract] [Full Text] [Related]
15. [Use of levosimendan in acute heart failure and its effect on renal function].
Moyano AP; Hidalgo RL; Grande DB; Morales SC
Nefrologia; 2009; 29(6):616-7. PubMed ID: 19936016
[No Abstract] [Full Text] [Related]
16. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
Biala A; Martonen E; Kaheinen P; Levijoki J; Finckenberg P; Merasto S; Louhelainen M; Muller DN; Luft FC; Mervaala E
Hypertens Res; 2010 Oct; 33(10):1004-11. PubMed ID: 20811386
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
Earl GL; Fitzpatrick JT
Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
[TBL] [Abstract][Full Text] [Related]
18. Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
[TBL] [Abstract][Full Text] [Related]
19. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.
Packer M; Colucci W; Fisher L; Massie BM; Teerlink JR; Young J; Padley RJ; Thakkar R; Delgado-Herrera L; Salon J; Garratt C; Huang B; Sarapohja T;
JACC Heart Fail; 2013 Apr; 1(2):103-11. PubMed ID: 24621834
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]